logo jchs

url jchs

 PREVIOUS ISSUE

  JUNE 2018
   VOLUME 3 ISSUE 1
   https://doi.org/10.24191/jchs.v3i1
   VOLUME 3 ISSUE 1 (S)
   https://doi.org/10.24191/jchs.v3i1(S)

EDITORIAL

  1. Competency-Based Medical Education, Here Next?
    Mohamad Fauzi Abdul Rani, Sabariah Abdul Rahman ; p1-4
    https://doi.org/10.24191/jchs.v3i1.6149
    PDF

CLINICAL QUIZ

  1. JCHS-CQ-01-2018
    Liyana Dhamirah Aminuddin, Tarita Taib, Meera Kuppusamy
    https://doi.org/10.24191/jchs.v3i1.6159
    PDF(Question)
    PDF(Answer)

Click Here to Download PDF Version

Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 1 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 2 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 3 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 4 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 5 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 6 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 7 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 8 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 9 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 10